ZNTL
Real-time Quotes | Nasdaq Last Sale
Based on 6 analysts
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 14,2021 17:06
8-K Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
Apr 06,2021 17:04
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 06,2021 17:40
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 06,2021 17:43
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 06,2021 17:46
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 06,2021 17:48
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 05,2021 19:49
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Apr 05,2021 19:54
10-K Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
Mar 25,2021 07:17
8-K Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
Mar 25,2021 07:04
S-8 Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
Mar 19,2021 16:28
8-K Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
Mar 19,2021 16:08
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 10,2021 20:26
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 08,2021 06:03
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 03,2021 16:35
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 03,2021 16:36
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 03,2021 16:37
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Mar 03,2021 16:37
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Feb 16,2021 19:01
4 Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
Feb 16,2021 19:01
Webull offers kinds of Zentalis Pharmaceuticals Inc stock information, including NASDAQ:ZNTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZNTL stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading ZNTL stock methods without spending real money on the virtual paper trading platform.